These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 11788891

  • 1. Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas.
    Kase S, Osaki M, Adachi H, Kaibara N, Ito H.
    Int J Oncol; 2002 Feb; 20(2):291-7. PubMed ID: 11788891
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H.
    Cancer Res; 1998 May 15; 58(10):2057-62. PubMed ID: 9605741
    [Abstract] [Full Text] [Related]

  • 3. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.
    J Immunol; 1998 Jun 01; 160(11):5669-75. PubMed ID: 9605174
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
    Shibakita M, Tachibana M, Dhar DK, Kotoh T, Kinugasa S, Kubota H, Masunaga R, Nagasue N.
    Clin Cancer Res; 1999 Sep 01; 5(9):2464-9. PubMed ID: 10499620
    [Abstract] [Full Text] [Related]

  • 5. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 01; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 6. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC, Barnetson RS, Halliday GM.
    Br J Dermatol; 2004 Jul 01; 151(1):42-9. PubMed ID: 15270871
    [Abstract] [Full Text] [Related]

  • 7. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA.
    Urology; 2004 Jun 01; 63(6):1198-204. PubMed ID: 15183989
    [Abstract] [Full Text] [Related]

  • 8. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
    Shukuwa T, Katayama I, Koji T.
    Mod Pathol; 2002 Apr 01; 15(4):387-96. PubMed ID: 11950912
    [Abstract] [Full Text] [Related]

  • 9. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
    Younes M, Schwartz MR, Ertan A, Finnie D, Younes A.
    Cancer; 2000 Feb 01; 88(3):524-8. PubMed ID: 10649242
    [Abstract] [Full Text] [Related]

  • 10. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
    Nagao M, Nakajima Y, Hisanaga M, Kayagaki N, Kanehiro H, Aomatsu Y, Ko S, Yagita H, Yamada T, Okumura K, Nakano H.
    Hepatology; 1999 Aug 01; 30(2):413-21. PubMed ID: 10421649
    [Abstract] [Full Text] [Related]

  • 11. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X, Hazarika P, Zhang C, Talpur R, Duvic M.
    Clin Cancer Res; 2001 Sep 01; 7(9):2682-92. PubMed ID: 11555580
    [Abstract] [Full Text] [Related]

  • 12. FasL:Fas ratio--a prognostic factor in breast carcinomas.
    Reimer T, Herrnring C, Koczan D, Richter D, Gerber B, Kabelitz D, Friese K, Thiesen HJ.
    Cancer Res; 2000 Feb 15; 60(4):822-8. PubMed ID: 10706087
    [Abstract] [Full Text] [Related]

  • 13. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC.
    Oncol Rep; 2003 Feb 15; 10(1):57-63. PubMed ID: 12469145
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors.
    Liu Y, Chen C, Chen C, Hsieh H, Chang C, Shyu J, Yen C, Harn H.
    J Surg Res; 2001 Feb 15; 95(2):92-8. PubMed ID: 11162031
    [Abstract] [Full Text] [Related]

  • 15. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K, Komuta K, Hashimoto S, Matsuzaki S, Kanematsu T, Koji T.
    Clin Cancer Res; 2000 Sep 15; 6(9):3560-4. PubMed ID: 10999744
    [Abstract] [Full Text] [Related]

  • 16. Fas/Fas ligand system and apoptosis induction in testicular carcinoma.
    Schmelz HU, Abend M, Kraft K, Hauck EW, Weidner W, Van Beuningen D, Sparwasser C.
    Cancer; 2002 Jul 01; 95(1):73-81. PubMed ID: 12115319
    [Abstract] [Full Text] [Related]

  • 17. Detection of Fas ligand in the bovine oviduct.
    Bergqvist AS, Killian G, Erikson D, Hoshino Y, Båge R, Sato E, Rodríguez-Martínez H.
    Anim Reprod Sci; 2005 Mar 01; 86(1-2):71-88. PubMed ID: 15721660
    [Abstract] [Full Text] [Related]

  • 18. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ, Ku JK, Kim MY, Kang H, Cho SH, Kim HO, Park YM.
    Br J Dermatol; 2006 Mar 01; 154(3):419-25. PubMed ID: 16445769
    [Abstract] [Full Text] [Related]

  • 19. Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system.
    Zhang S, Zeng G, Kao C, Gardner T, Sweeney C, Yang NS, Eble JN, Cheng L.
    Prostate; 2002 Sep 15; 53(1):69-76. PubMed ID: 12210482
    [Abstract] [Full Text] [Related]

  • 20. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S, Nagao M, Kanehiro H, Hisanaga M, Ko S, Ikeda N, Nakajima Y.
    Anticancer Res; 2004 Sep 15; 24(3a):1569-79. PubMed ID: 15274324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.